FDA NDC Directory · JSON-LD · Markdown

NAGLAZYME

NDC 68135-020 · HUMAN PRESCRIPTION DRUG · SOLUTION

Generic namegalsulfase
Labeler / ManufacturerBioMarin Pharmaceutical Inc.
Marketing categoryBiologic License Application · App BLA125117
Dosage form / routeSOLUTION · INTRAVENOUS
Active ingredientsGALSULFASE (5 mg/5mL)
Marketing started20050609
Package count1

External sources

Source: openFDA. Public-domain (CC0).